Origins and functions of B-1 cells with notes on the role of CD5.
暂无分享,去创建一个
[1] J. Gommerman,et al. Negative selection of B lymphocytes: a novel role for innate immunity , 2000, Immunological reviews.
[2] F. Alt,et al. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines , 1984, Nature.
[3] B. Koller,et al. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.
[4] S. Smith‐Gill,et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.
[5] J. García-Porrero,et al. Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors , 1993, Nature.
[6] P. Youinou,et al. CD5 expression in human B-cell populations. , 1999, Immunology today.
[7] R. Hardy,et al. Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. , 1986, Science.
[8] C. Snapper,et al. B‐cell activation by T‐cell‐independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms , 2000, Immunological reviews.
[9] P. Pereira,et al. Further evidence for coelomic‐associated b lymphocytes , 1989, European journal of immunology.
[10] K. Rajewsky,et al. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. , 1988, The EMBO journal.
[11] J. Bajorath,et al. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM. , 1996, Biochemistry.
[12] D. Ramsden,et al. In vitro maturation of clonal CD4+CD8+ cell lines in response to TCR engagement. , 1995, Journal of immunology.
[13] A. Theofilopoulos,et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.
[14] D. Tillman,et al. Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse. , 1990, Journal of immunology.
[15] M. Neuberger,et al. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Akira,et al. Cutting Edge: Essential Role of Phospholipase C-γ2 in B Cell Development and Function1 , 2000, The Journal of Immunology.
[17] R. Hardy,et al. A VH11Vκ9 B Cell Antigen Receptor Drives Generation of CD5+ B Cells Both In Vivo and In Vitro1 , 2000, The Journal of Immunology.
[18] R. Flavell,et al. Distinct Roles in Lymphoid Organogenesis for Lymphotoxins α and β Revealed in Lymphotoxin β–Deficient Mice , 1997 .
[19] J. Karras,et al. Signal Transducer and Activator of Transcription-3 (STAT3) Is Constitutively Activated in Normal, Self-renewing B-1 Cells but Only Inducibly Expressed in Conventional B Lymphocytes , 1997, The Journal of experimental medicine.
[20] F. Mackay,et al. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs , 1996, The Journal of experimental medicine.
[21] L. Herzenberg,et al. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. , 1997, Journal of immunology.
[22] K. Rajewsky,et al. Expansion and functional activity of Ly‐1+ B cells upon transfer of peritoneal cells into allotype‐congenic, newborn mice , 1987, European journal of immunology.
[23] Y. Takahama,et al. Heterogeneous Expression of Recombination Activating Genes and Surface CD5 in CD3low CD4+CD8+ Thymocytes , 1996, Scandinavian journal of immunology.
[24] C. Thompson,et al. Avian B cell development. , 1997, International reviews of immunology.
[25] M. Carroll,et al. Linkages of innate and adaptive immunity. , 1998, Current opinion in immunology.
[26] A. Tarakhovsky,et al. Negative regulation of CD4 lineage development and responses by CD5. , 1999, Journal of immunology.
[27] R. Hardy,et al. B‐cell commitment, development and selection , 2000, Immunological reviews.
[28] M. Jackson,et al. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen , 1996, The Journal of experimental medicine.
[29] K. Lam,et al. B-1 cells: unique origins and functions. , 1996, Seminars in immunology.
[30] A. Rolink,et al. Repertoire selection by pre‐B‐cell receptors and B‐cell receptors, and genetic control of B‐cell development from immature to mature B cells , 2000, Immunological reviews.
[31] C. Jamin,et al. CD5+B Cells: Differential Capping and Modulation of IgM and CD5 , 1996, Scandinavian journal of immunology.
[32] D. Briles,et al. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody , 1982, Infection and immunity.
[33] T. Honjo,et al. Expression Levels of B Cell Surface Immunoglobulin Regulate Efficiency of Allelic Exclusion and Size of Autoreactive B-1 Cell Compartment , 1999, The Journal of experimental medicine.
[34] C. Park,et al. Fine Tuning of TCR Signaling by CD5 , 2001, The Journal of Immunology.
[35] R. Zinkernagel,et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. , 2000, Science.
[36] P. Bruhns,et al. The Pseudo-immunoreceptor Tyrosine-based Activation Motif of CD5 Mediates Its Inhibitory Action on B-cell Receptor Signaling* , 2000, The Journal of Biological Chemistry.
[37] S. Hirose,et al. Distinct surface phenotypes of B cells responsible for spontaneous production of IgM and IgG anti-DNA antibodies in autoimmune-prone NZB x NZW F1 mice. , 1990, Autoimmunity.
[38] L. Corcoran,et al. oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function. , 1997, Journal of immunology.
[39] H. Wortis,et al. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. , 1991, International immunology.
[40] R. Siegel,et al. To B or not to B: TNF family signaling in lymphocytes , 2001, Nature Immunology.
[41] R. Barton,et al. Ontogeny of terminal deoxynucleotidyl transferase-positive cells in lymphohemopoietic tissues of rat and mouse. , 1979, Journal of immunology.
[42] G. Freeman,et al. Expression and regulation of CD5 on in vitro activated human B cells , 1989, European journal of immunology.
[43] B. Haynes,et al. CD6-ligand interactions: a paradigm for SRCR domain function? , 1997, Immunology today.
[44] N. Baumgarth,et al. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. , 1999, Immunity.
[45] S. Dillon,et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. , 2001, Immunity.
[46] J. Strominger,et al. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[47] L. Herzenberg,et al. Origin of murine B cell lineages. , 1993, Annual review of immunology.
[48] H. Wortis,et al. Regulation of thymus-independent responses: unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies. , 1980, Journal of immunology.
[49] T. Honjo,et al. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse , 1994, The Journal of experimental medicine.
[50] J. Cleveland,et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. , 2000, Immunity.
[51] Taku Sato,et al. Aberrant High Expression of B Lymphocyte Chemokine (Blc/Cxcl13) by C11b+Cd11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells towards Blc , 2001, The Journal of experimental medicine.
[52] J. Bajorath,et al. The Amino-terminal Immunoglobulin-like Domain of Activated Leukocyte Cell Adhesion Molecule Binds Specifically to the Membrane-proximal Scavenger Receptor Cysteine-rich Domain of CD6 with a 1:1 Stoichiometry* , 1996, The Journal of Biological Chemistry.
[53] R. Berland,et al. Role of NFAT in the regulation of B-1 cells. , 2000, Current topics in microbiology and immunology.
[54] T. Rothstein,et al. Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells. , 1988, Journal of immunology.
[55] L. Herzenberg,et al. Feedback regulation of murine Ly‐1 B cell development , 1989, European journal of immunology.
[56] T. Serikawa,et al. Effects of Breeding Environments on Generation and Activation of Autoreactive B-1 Cells in Anti-red Blood Cell Autoantibody Transgenic Mice , 1997, The Journal of experimental medicine.
[57] T. Honjo,et al. A transgenic model of autoimmune hemolytic anemia , 1992, The Journal of experimental medicine.
[58] K. Rajewsky,et al. The repertoire of somatic antibody mutants accumulating in the memory compartment after primary immunization is restricted through affinity maturation and mirrors that expressed in the secondary response , 1990, The Journal of experimental medicine.
[59] Jianzhu Chen,et al. B-1 and B-2 Cell–Derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection , 2000, The Journal of experimental medicine.
[60] T. Onodera,et al. AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF‐β1 , 1999, European journal of immunology.
[61] S. Clarke,et al. B-1 Cell Development: Evidence for an Uncommitted Immunoglobulin (Ig)M+ B Cell Precursor in B-1 Cell Differentiation , 1998, The Journal of experimental medicine.
[62] T. Winkler,et al. IL-2 receptor α chain (CD25JAC) expression defines a crucial stage in pre-B cell development , 1994 .
[63] M. Krieger,et al. The SRCR superfamily: a family reminiscent of the Ig superfamily. , 1994, Trends in biochemical sciences.
[64] F. Grosveld,et al. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage. , 1996, The EMBO journal.
[65] T. Serikawa,et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.
[66] S. Alberti,et al. MRC OX19 recognizes the rat CD5 surface glycoprotein, but does not provide evidence for a population of CD5bright B cells , 1994, European journal of immunology.
[67] S. Clarke,et al. Biased immunoglobulin variable region gene expression by Ly‐1 B cells due to clonal selection , 1989, European journal of immunology.
[68] P. Wernet,et al. Human B cell development. II. Subpopulations in the human fetus. , 1985, Journal of immunology.
[69] J. Mcghee,et al. Alternate Mucosal Immune System: Organized Peyer’s Patches Are Not Required for IgA Responses in the Gastrointestinal Tract1 , 2000, The Journal of Immunology.
[70] J. Kearney,et al. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. , 2000, Immunity.
[71] J. Whitsett,et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. , 1995, The Journal of clinical investigation.
[72] D. Shotton,et al. Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1. , 1998, European journal of biochemistry.
[73] K. Hayakawa,et al. Cell-to-cell interaction controlled by immunoglobulin genes. Role of Thy-1-, Lyt-1+, Ig+ (B') cell in allotype-restricted antibody production , 1982, The Journal of experimental medicine.
[74] M. Crumpton,et al. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[75] A. Marshall,et al. Frequency of VH81x usage during B cell development: initial decline in usage is independent of Ig heavy chain cell surface expression. , 1996, Journal of immunology.
[76] G. Kollias,et al. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[77] J. Reynolds. The genesis, tutelage and exodus of B cells in the ileal Peyer's patch of sheep. , 1997, International reviews of immunology.
[78] J. Kearney,et al. Development of VH81X transgene-bearing B cells in fetus and adult: sites for expansion and deletion in conventional and CD5/B1 cells. , 1997, International immunology.
[79] R. Karr,et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[80] E. Tan,et al. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice. , 1983, Journal of immunology.
[81] Jianzhu Chen,et al. A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.
[82] J. Kearney,et al. B‐cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory” , 2000, Immunological reviews.
[83] J. Lalouel,et al. Lipoprotein Lipase Binds to Low Density Lipoprotein Receptors and Induces Receptor-mediated Catabolism of Very Low Density Lipoproteins in Vitro* , 1996, The Journal of Biological Chemistry.
[84] A. Grinberg,et al. CD5 Expression Is Developmentally Regulated By T Cell Receptor (TCR) Signals and TCR Avidity , 1998, The Journal of experimental medicine.
[85] M. Nasu,et al. Immunophenotyping of lymphocytes in the lung interstitium and expression of osteopontin and interleukin-2 mRNAs in two different murine models of pulmonary fibrosis. , 1998, Experimental lung research.
[86] R. Hardy,et al. Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein , 1990, The Journal of experimental medicine.
[87] C. Mohan,et al. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. , 1998, Arthritis and rheumatism.
[88] A. Coutinho,et al. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact , 1997, European journal of immunology.
[89] T. Kishimoto,et al. Somatic diversification and affinity maturation of IgM and IgG anti‐DNA antibodies in murine lupus , 1993, European journal of immunology.
[90] S. Bondada,et al. Negative regulation of antigen receptor‐mediated signaling by constitutive asociation of CD5 with the SHP‐1 protein tyrosine phosphatase in B‐1 B cells , 1999, European journal of immunology.
[91] B. Fowlkes,et al. Early T lymphocytes. Differentiation in vivo of adult intrathymic precursor cells , 1985, The Journal of experimental medicine.
[92] W. Leiserson,et al. Expression of Lyt-1 by a subset of B lymphocytes. , 1982, Journal of immunology.
[93] N. Yamaguchi,et al. Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. , 1990, Journal of immunology.
[94] F. Kroese,et al. B-1 cells and the intestinal microflora. , 2000, Current topics in microbiology and immunology.
[95] R. Hardy,et al. Immunoglobulin‐bearing B cells reconstitute and maintain the murine Ly‐1 B cell lineage , 1986, European journal of immunology.
[96] M. Apicella,et al. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. , 1991, Journal of immunology.
[97] B. J. Helyer,et al. The immunology and pathology of NZB mice. , 1968, Advances in immunology.
[98] N. Talal,et al. B cells expressing CD5 are increased in Sjögren's syndrome. , 1988, Arthritis and rheumatism.
[99] C. Buechler,et al. Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C , 2001, European journal of immunology.
[100] S. Morikawa,et al. Induction of CD5 antigen on human CD5- B cells by stimulation with Staphylococcus aureus Cowan strain I. , 1993, International immunology.
[101] R. Pabst,et al. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes , 2001, Journal of Neuroimmunology.
[102] Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[103] T. Honjo,et al. Involvement of IL-10 in induction of autoimmune hemolytic anemia in anti-erythrocyte Ig transgenic mice. , 1998, International immunology.
[104] T. Honjo,et al. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. , 1995, International immunology.
[105] Katsuhiko Hayashi,et al. The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[106] E. Butcher,et al. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. , 1989, International immunology.
[107] R. Hardy,et al. Development and function of B-1 cells. , 2000, Current opinion in immunology.
[108] J. Miyazaki,et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production , 1991, The Journal of experimental medicine.
[109] G. Appleyard,et al. Porcine CD5 gene and gene product identified on the basis of inter-species conserved cytoplasmic domain sequences. , 1998, Veterinary immunology and immunopathology.
[110] L. Herzenberg,et al. The regulation of CD5 expression in murine T cells , 2001, BMC Molecular Biology.
[111] J. Allison,et al. Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation. , 1986, Journal of immunology.
[112] P. Hodgkin,et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.
[113] L. Herzenberg,et al. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[114] G. Silverman,et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.
[115] J. Renauld,et al. Interleukin 9–induced In Vivo Expansion of the B-1 Lymphocyte Population , 1999, The Journal of experimental medicine.
[116] F. Agenès,et al. Transfer of Small Resting B Cells into Immunodeficient Hosts Results in the Selection of a Self-renewing Activated B Cell Population , 1999, The Journal of experimental medicine.
[117] H. Wortis,et al. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. , 1995, International immunology.
[118] C. Janeway,et al. IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. , 1989, Journal of immunology.
[119] M. Reth,et al. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. , 1999, Immunity.
[120] K. Rajewsky,et al. Lymphocyte populations and immune responses in CD5‐deficient mice , 1994, European journal of immunology.
[121] Y. Chuang,et al. In vitro and in vivo functional analysis of CD5+ and CD5− B cells of autoimmune NZB × NZW F1 mice , 1996 .
[122] C. Snapper,et al. T cell-independent antigens type 2. , 1995, Annual review of immunology.
[123] Klaus Rajewsky,et al. Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.
[124] V. Godfrey,et al. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. , 1995, Journal of immunology.
[125] S. Stacker,et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.
[126] J. Silver,et al. Positive selection of natural autoreactive B cells. , 1999, Science.
[127] D. Morris,et al. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes , 1993, The Journal of experimental medicine.
[128] D. Campana,et al. An essential role for BLNK in human B cell development. , 1999, Science.
[129] K. Rajewsky,et al. B Cell Antigen Receptor Specificity and Surface Density Together Determine B-1 versus B-2 Cell Development , 1999, The Journal of experimental medicine.
[130] J. Browning,et al. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. , 1997, International immunology.
[131] M. Neuberger,et al. Deficiency in CD22, a B Cell–specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies , 1999, The Journal of experimental medicine.
[132] K. Frederiksen,et al. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. , 1982, The Journal of clinical investigation.
[133] L. Bentolila,et al. Terminal deoxynucleotidyl transferase expression during neonatal life alters D(H) reading frame usage and Ig-receptor-dependent selection of V regions. , 1998, Journal of immunology.
[134] P. Huie,et al. Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines , 1998, The Journal of experimental medicine.
[135] C. Rudd,et al. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[136] J. Cyster,et al. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. , 1995, Immunity.
[137] A. Meyer,et al. Immunoglobulin gene diversification in cattle. , 1997, International reviews of immunology.
[138] G. Köhler,et al. CD22 is a negative regulator of B-cell receptor signalling , 1997, Current Biology.
[139] A. Cheng,et al. Requirement for B cell linker protein (BLNK) in B cell development. , 1999, Science.
[140] R. Hardy,et al. CD5 B cells, a fetal B cell lineage. , 1994, Advances in immunology.
[141] S. Shinton,et al. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. , 1989, Journal of immunology.
[142] I. Stamenkovic,et al. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes , 1996, The Journal of experimental medicine.
[143] O. Vainio,et al. The structure of avian CD5 implies a conserved function. , 1998, Journal of immunology.
[144] T. Imanishi‐Kari,et al. Adult bone marrow contains precursors for CD5+ B cells , 1996, European journal of immunology.
[145] M. Steward,et al. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. , 1976, Clinical and experimental immunology.
[146] U. Hámmerling,et al. Immunogenetics of Mouse B‐Cell Alloantigen Systems Defined by Monoclonal Antibodies and Gene‐Cluster Formation of these Loci , 1983, Immunological reviews.
[147] Y. Yazaki,et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. , 1999, Science.
[148] J. Kearney,et al. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.
[149] A. Rolink,et al. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells , 1992, The Journal of experimental medicine.
[150] R. Hardy,et al. Rheumatoid factor secretion from human Leu-1+ B cells. , 1987, Science.
[151] R. Hardy,et al. Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? , 1988, Annual review of immunology.
[152] D. Briles,et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae , 1981, The Journal of experimental medicine.
[153] F. Alt,et al. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.
[154] S. Shinton,et al. B-1 cell definition. , 2000, Current topics in microbiology and immunology.
[155] D. Nemazee,et al. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes , 1989, Nature.
[156] A. Singer,et al. Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28 , 1994, The Journal of experimental medicine.
[157] T. Honjo,et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice , 1992, Nature.
[158] C. Raman,et al. CD5+ B cells predominate in peripheral tissues of rabbit. , 1992, Journal of immunology.
[159] A. Rolink,et al. Fetal liver organ cultures allow the proliferative expansion of pre-B receptor-expressing pre-B-II cells and the differentiation of immature and mature B cells in vitro. , 1998, International immunology.
[160] A. Strasser,et al. Lymphocyte Survival--Ignorance Is BLys , 2000, Science.
[161] A. Aruffo,et al. Molecular cloning, genomic organization and cell‐binding characteristicsof mouse Spα , 2000, Immunology.
[162] L. Herzenberg. B‐1 cells: the lineage question revisited , 2000, Immunological reviews.
[163] F. Alt,et al. Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice , 1990, The Journal of experimental medicine.
[164] K. Sheehan,et al. Molecular cloning of the primary IgH repertoire: a quantitative analysis of VH gene usage in adult mice. , 1989, The EMBO journal.
[165] K. Rajewsky,et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. , 1995, Science.
[166] T. Logtenberg,et al. The majority of human tonsillar CD5+ B cells express somatically mutated Vχ4 genes , 1993 .
[167] A. Whitmore,et al. B-1 cells are made, not born. , 1993, Immunology today.
[168] J. Tschopp,et al. Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.
[169] M. Harigai,et al. IL‐4 down‐regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM‐rheumatoid factor production in patients with rheumatoid arthritis , 1992, Clinical and experimental immunology.
[170] R. Hardy,et al. A developmental switch in B lymphopoiesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[171] A. Satterthwaite,et al. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. , 2000, Immunological reviews.
[172] S. Ikehara,et al. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice , 1994, European journal of immunology.
[173] B. Morgan,et al. Aiolos regulates B cell activation and maturation to effector state. , 1998, Immunity.
[174] A. Kuo,et al. Regulation of Casein Kinase 2 by Direct Interaction with Cell Surface Receptor CD5* , 1998, The Journal of Biological Chemistry.
[175] P. Brennan,et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. , 1995, Science.
[176] H. Van de Velde,et al. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). , 1992, Journal of immunology.
[177] T. Watanabe,et al. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice , 1996, The Journal of experimental medicine.
[178] H. Kiyono,et al. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. , 1999, Journal of immunology.
[179] L. Samelson,et al. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.
[180] J. Latham Claflin,et al. CLONAL NATURE OF THE IMMUNE RESPONSE TO PHOSPHORYLCHOLINE , 1974, The Journal of experimental medicine.
[181] M. Neuberger,et al. Hyperresponsive B Cells in CD22-Deficient Mice , 1996, Science.
[182] M. Hatano,et al. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[183] K. Rajewsky,et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.
[184] R. Hardy,et al. Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence , 1983, Nature.
[185] J. Bajorath,et al. Identification of residues in CD6 which are critical for ligand binding. , 1997, Biochemistry.
[186] H. Wortis,et al. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[187] S. Clarke,et al. The transition of pre‐BI to pre‐BII cells is dependent on the VH structure of the mu/surrogate L chain receptor. , 1996, The EMBO journal.
[188] D. Gray,et al. B cell memory to thymus‐independent antigens type 1 and type 2: the role of lipopolysaccharide in B memory induction , 1988, European journal of immunology.
[189] M. Howard,et al. Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10 , 1992, European journal of immunology.
[190] K. Pfeffer,et al. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor , 1996, The Journal of experimental medicine.
[191] R. Hardy,et al. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[192] H. Velde,et al. The B-cell surface protein CD72/Lyb-2 is the ligand for CDS , 1991, Nature.
[193] T. Rothstein,et al. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. , 1988, Journal of immunology.
[194] K. Horikawa,et al. A Double-Edged Kinase Lyn: A Positive and Negative Regulator for Antigen Receptor–mediated Signals , 1998, The Journal of experimental medicine.
[195] S. Clarke,et al. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression , 1994, The Journal of experimental medicine.
[196] U. Francke,et al. Molecular Cloning, Mapping to Human Chromosome 1 q21-q23, and Cell Binding Characteristics of Spα, a New Member of the Scavenger Receptor Cysteine-rich (SRCR) Family of Proteins* , 1997, The Journal of Biological Chemistry.
[197] R. Eisenberg,et al. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice , 1993, The Journal of experimental medicine.
[198] L. Herzenberg,et al. De novo development and self-replenishment of B cells. , 1995, International immunology.
[199] R. Zinkernagel,et al. IgD can largely substitute for loss of IgM function in B cells , 1998, Nature.
[200] R. Zinkernagel,et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice , 1996 .
[201] K. Siminovitch,et al. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase , 1996, The Journal of experimental medicine.
[202] J. Sprent,et al. Several Different Cell Surface Molecules Control Negative Selection of Medullary Thymocytes , 1999, The Journal of experimental medicine.
[203] L. Herzenberg,et al. Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens * , 1979, Immunological reviews.
[204] L. Old,et al. Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse , 1968, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[205] Robert B Sim,et al. Molecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering. , 1993, The Biochemical journal.
[206] Don Foster,et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.
[207] J. Allison,et al. Altered expression of lymphocyte differentiation antigens on phorbol ester-activated CD4+8+ T cells. , 1988, Journal of immunology.
[208] J. Marth,et al. Distinct differentiative stages of CD4+CD8+ thymocyte development defined by the lack of coreceptor binding in positive selection. , 1995, Journal of immunology.
[209] A. Whitmore,et al. Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. , 1996, International immunology.
[210] S. Kanner,et al. CD5 Negatively Regulates the T-Cell Antigen Receptor Signal Transduction Pathway: Involvement of SH2-Containing Phosphotyrosine Phosphatase SHP-1 , 1999, Molecular and Cellular Biology.
[211] G. Inghirami,et al. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. , 1987, Science.
[212] R. Hardy,et al. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver , 1993, The Journal of experimental medicine.
[213] D. Tillman,et al. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice , 1992, The Journal of experimental medicine.
[214] D. Cohen,et al. Induction of phorbol ester responsiveness in conventional B cells after activation via surface Ig. , 1991, Journal of immunology.
[215] K. Rajewsky,et al. T Cell‐Dependent Antibody Production by Ly‐1 B Cells a , 1992, Annals of the New York Academy of Sciences.
[216] D. Pisetsky,et al. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. , 1996, Journal of immunology.
[217] L. Herzenberg,et al. The LY‐1B Cell Lineage , 1986 .
[218] A. Tarakhovsky,et al. Immunodeficiency in Protein Kinase Cβ-Deficient Mice , 1996, Science.
[219] Kenneth G. C. Smith,et al. Inhibition of the B Cell by CD22: A Requirement for Lyn , 1998, The Journal of experimental medicine.
[220] M. Crumpton,et al. Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes , 1992, European journal of immunology.
[221] A. Coutinho,et al. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. , 1990, International immunology.
[222] J. Kearney,et al. CD5 transgenic mice. , 1995, Current topics in microbiology and immunology.
[223] D. Plas,et al. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. , 1999, Journal of immunology.
[224] R. Benner,et al. The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes. , 1988, Cellular immunology.
[225] A. Singer,et al. The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype‐independent CD3 complexes. , 1995, The EMBO journal.
[226] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[227] G. M. Fischer,et al. STAT3 activation, chemokine receptor expression, and cyclin-Cdk function in B-1 cells. , 2000, Current topics in microbiology and immunology.
[228] G. J. Deenen,et al. Location and Function of B‐Cell Lineages a , 1992, Annals of the New York Academy of Sciences.
[229] Robbert Benner,et al. Isotypes and specificities of immunoglobulins produced by germ‐free mice fed chemically defined ultrafiltered “antigen‐free” diet , 1984, European journal of immunology.
[230] A. Aruffo,et al. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. , 1998, International immunology.
[231] T. Tedder,et al. Lupus-Specific Antiribonucleoprotein B Cell Tolerance in Nonautoimmune Mice Is Maintained by Differentiation to B-1 and Governed by B Cell Receptor Signaling Thresholds1 , 2001, The Journal of Immunology.
[232] E. Harhaj,et al. NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .
[233] M. Crumpton,et al. Physical association of CD5 and the T cell receptor/CD3 antigen complex on the surface of human T lymphocytes , 1993, European journal of immunology.
[234] N. Chiorazzi,et al. Expression of CD5 and CD38 by human CD5− B cells: Requirement for special stimuli , 1994, European journal of immunology.
[235] R. Hardy,et al. Peritoneal Ly‐1 B cells: Genetic control, autoantibody production, increased lambda light chain expression , 1986, European journal of immunology.
[236] S. Porcelli,et al. Recognition of a lipid antigen by GDI-restricted αβ+ T cells , 1994, Nature.
[237] S. Bondada,et al. CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B Cells , 1996, Science.
[238] P. Linsley,et al. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins , 1991, The Journal of experimental medicine.
[239] T. Imanishi‐Kari,et al. The effect of an immunoglobulin μ transgene on B cell maturation , 1992, European journal of immunology.
[240] J. Kearney,et al. An embryonic source of Ly1 but not conventional B cells. , 1991, International immunology.
[241] C. Tatu,et al. Identification of a Precursor to Phosphatidyl Choline-Specific B-1 Cells Suggesting That B-1 Cells Differentiate from Splenic Conventional B Cells In Vivo: Cyclosporin A Blocks Differentiation to B-11 , 2000, The Journal of Immunology.
[242] S. Strober,et al. Cutting Edge: A Role for CD1 in the Pathogenesis of Lupus in NZB/NZW Mice1 , 2000, The Journal of Immunology.
[243] C. Y. Wang,et al. Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells , 1980, The Journal of experimental medicine.
[244] M. Naito,et al. Increased Susceptibility of Thymocytes to Apoptosis in Mice Lacking AIM, a Novel Murine Macrophage-derived Soluble Factor Belonging to the Scavenger Receptor Cysteine-rich Domain Superfamily , 1999, The Journal of experimental medicine.
[245] S. Pillai,et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. , 2001, Immunity.
[246] T. Honjo,et al. Administration of interleukin ‐5 or ‐10 activates peritoneal B‐1 cells and induces autoimmune hemolytic anemia in anti‐erythrocyte autoantibody‐transgenic mice , 1995, European journal of immunology.
[247] M. Shlomchik,et al. A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.
[248] C. Baldwin,et al. Monoclonal antibody BLT-1, specific for the bovine homologue of CD5, reacts with the majority of mature T cells, a subpopulation of B cells and stimulates T cell proliferation. , 1995, Developmental and comparative immunology.
[249] R. Berland,et al. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. , 1998, Journal of immunology.
[250] R. Perlmutter,et al. CD22 regulates thymus-independent responses and the lifespan of B cells , 1996, Nature.
[251] R. V. van Lier,et al. CD5 is associated with the human B cell antigen receptor complex , 1994, European journal of immunology.
[252] J. Ahearn,et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.
[253] V. Lang,et al. In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes. , 1997, Journal of immunology.
[254] R. Miller,et al. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA). , 1984, Journal of immunology.
[255] Christopher C. Goodnow,et al. Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.
[256] S. Sasaki,et al. Germfree mice reared on an "antigen-free" diet. , 1978, Laboratory animal science.
[257] M. Bowen,et al. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand , 1999, European journal of immunology.
[258] Philippe Soriano,et al. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. , 1997, Immunity.
[259] M. Freeman,et al. An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[260] K. Knight,et al. B lymphocyte development in the rabbit. , 1997, International reviews of immunology.
[261] R. Hardy,et al. Development and Physiology of LY‐1 B and its Human Homolog, LEU‐1 B , 1986, Immunological reviews.
[262] F. Alt,et al. Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.
[263] R. C. Schwartz,et al. Cloning of the murine CD5 promoter and its tissue-specific regulation. , 1995, Journal of immunology.
[264] T. Behrens,et al. Cd5 Maintains Tolerance in Anergic B Cells , 2000, The Journal of experimental medicine.
[265] R. Good,et al. Up-regulation and down-regulation of cell surface and mRNA expression of CD5 antigen by various humoral factors on murine 70Z/3 pre-B cell leukemia cell line: IL-4 down-regulates CD5 antigen expression. , 1990, Cellular immunology.
[266] A. Bauch,et al. Interaction of the CD5 cytoplasmic domain with the Ca2+ /calmodulin‐dependent kinase IIδ , 1998, European journal of immunology.
[267] M. Gershwin,et al. B‐1a and conventional B cells from autoimmune NZB. H‐2bm12 mice exhibit similar functional characteristics in vivo , 1993, European journal of immunology.
[268] D. Isenberg,et al. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. , 1990, Arthritis and rheumatism.
[269] R. Hardy,et al. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice , 1983, The Journal of experimental medicine.
[270] J. Kearney,et al. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses , 1997, European journal of immunology.
[271] R. Timpl,et al. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily , 1999, Nature Structural Biology.
[272] Scott F. Smith,et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.
[273] Wei Wei Wu,et al. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. , 2000, International immunology.
[274] M. Pujana,et al. Genomic organization of the human CD5 gene , 2000, Immunogenetics.
[275] L. Hood,et al. Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes. , 1984, Journal of immunology.
[276] A. Czernik,et al. Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes , 1995, The Journal of experimental medicine.
[277] Jianzhu Chen,et al. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.
[278] T. Honjo,et al. Alymphoplasia (aly)-Type Nuclear Factor κB–Inducing Kinase (Nik) Causes Defects in Secondary Lymphoid Tissue Chemokine Receptor Signaling and Homing of Peritoneal Cells to the Gut-Associated Lymphatic Tissue System , 2000, The Journal of experimental medicine.
[279] A. Bernstein,et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes , 1995, Molecular and cellular biology.
[280] F. Rosen,et al. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. , 1997, Journal of immunology.
[281] M. Parsons,et al. TCR engagement of CD4+CD8+ thymocytes in vitro induces early aspects of positive selection, but not apoptosis. , 1997, Journal of immunology.
[282] F. Alt,et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.
[283] J. Cyster,et al. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. , 1998, Immunity.
[284] M. Howard,et al. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells , 1992, The Journal of experimental medicine.
[285] A. Rolink,et al. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. , 1997, Immunity.
[286] Polack,et al. B‐1‐like cells exist in sheep. Characterization of their phenotype and behaviour , 1998, Immunology.
[287] A. Coutinho,et al. Origin of CD5+ B cells and natural IgM‐secreting cells: reconstitution potential of adult bone marrow, spleen and peritoneal cells , 1992, European journal of immunology.
[288] D. Andreu,et al. Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. , 1998, Journal of immunology.
[289] A. Miller,et al. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. , 1996, Immunity.
[290] J. Miyazaki,et al. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.
[291] J. Strominger,et al. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1 , 1986, Nature.